Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.

Hedberg ML, Goh G, Chiosea SI, Bauman JE, Freilino ML, Zeng Y, Wang L, Diergaarde BB, Gooding WE, Lui VW, Herbst RS, Lifton RP, Grandis JR.

J Clin Invest. 2016 Apr 1;126(4):1606. doi: 10.1172/JCI86862. Epub 2016 Apr 1. No abstract available.

2.

S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.

Yokota T, Onozawa Y, Boku N, Hamauchi S, Tsushima T, Taniguchi H, Todaka A, Machida N, Yamazaki K, Fukutomi A, Yasui H.

Jpn J Clin Oncol. 2011 Dec;41(12):1351-7. doi: 10.1093/jjco/hyr147. Epub 2011 Oct 5.

PMID:
21980053
3.

Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Hitt R, Amador ML, Quintela-Fandino M, Jimeno A, del Val O, Hernando S, Cortes-Funes H.

Cancer. 2006 Jan 1;106(1):106-11.

4.

Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens.

Massa E, Dessì M, Gaspardini G, Saba F, Cherchi V, Mantovani G.

Oral Oncol. 2010 Nov;46(11):818-21. doi: 10.1016/j.oraloncology.2010.08.013.

PMID:
20920877
5.

Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.

Kiyota N, Tahara M, Kadowaki S, Fuse N, Doi T, Minami H, Ohtsu A.

Jpn J Clin Oncol. 2009 Apr;39(4):225-30. doi: 10.1093/jjco/hyp002. Epub 2009 Feb 10.

PMID:
19211574
6.

Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.

Cho H, Nishiike S, Yamamoto Y, Takenaka Y, Nakahara S, Yasui T, Hanamoto A, Inohara H.

Auris Nasus Larynx. 2015 Oct;42(5):396-400. doi: 10.1016/j.anl.2015.02.009. Epub 2015 Feb 23.

PMID:
25721854
7.

Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.

Semin Oncol. 1998 Apr;25(2 Suppl 4):40-4; discussion 45-8.

PMID:
9578061
8.

Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.

Le Tourneau C, Siu LL.

Curr Opin Oncol. 2008 May;20(3):256-63. doi: 10.1097/CCO.0b013e3282f9b575. Review.

PMID:
18391623
9.

Patterns of spread in recurrent head and neck squamous cell carcinoma.

Vaidya AM, Petruzzelli GJ, Clark J, Emami B.

Otolaryngol Head Neck Surg. 2001 Oct;125(4):393-6.

PMID:
11593178
10.

[Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].

Nishio M, Kagami Y, Narimatsu N, Asano K, Sanbe S, Somekawa Y.

Gan To Kagaku Ryoho. 1989 Sep;16(9):3111-8. Japanese.

PMID:
2476971
11.

Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions.

Khuri FR, Shin DM, Glisson BS, Lippman SM, Hong WK.

Semin Oncol. 2000 Aug;27(4 Suppl 8):25-33. Review.

PMID:
10952435
12.

Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N, Hitt R.

N Engl J Med. 2008 Sep 11;359(11):1116-27. doi: 10.1056/NEJMoa0802656.

13.

The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck.

Palme CE, MacKay SG, Kalnins I, Morgan GJ, Veness MJ.

Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):103-6. Review.

PMID:
17413411
14.
15.

Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Ginsberg L, Lawhorn K, Hong WK, Lippman SM.

Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-33-S19-37.

PMID:
9427263
16.
17.
18.

SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.

Eibling DE, Johnson JT, Wagner RL, Su S.

Laryngoscope. 1989 Feb;99(2):117-24.

PMID:
2913421
19.
20.

The role of cetuximab in the treatment of squamous cell cancer of the head and neck.

Burtness B.

Expert Opin Biol Ther. 2005 Aug;5(8):1085-93. Review.

PMID:
16050785

Supplemental Content

Support Center